Spirig Pharma AG, Egerkingen, Switzerland.
Skin Pharmacol Physiol. 2012;25(3):155-61. doi: 10.1159/000336789. Epub 2012 Mar 6.
Therapy of atopic dermatitis encloses use of medicated and nonmedicated preparations. Results of clinical and biophysical procedures indirectly describe the condition of the impaired skin barrier (SB). Direct evaluation of SB integrity is only possible by electron microscopical visualization, e.g. intercellular lipid lamellae (ICLL) organization of the stratum corneum.
SB integrity was measured by morphometric analysis of ICLL in healthy and atopic skin and after a 15-day treatment (plus 7-day follow-up) of atopic skin with a glycerin preparation.
Significant treatment effect was shown by the restoration of the ICLL.
The study reveals that morphometric analysis of ICLL organization is suitable to differentiate between healthy and diseased skin and to semiquantitatively determine the effect of a nonmedicated glycerin formulation.
Small treatment cohort.
特应性皮炎的治疗包括使用药物和非药物制剂。临床和生物物理程序的结果间接描述了受损的皮肤屏障 (SB) 的情况。只有通过电子显微镜观察,例如角质层细胞间脂质层 (ICLL) 的组织,才能直接评估 SB 的完整性。
通过对健康和特应性皮炎皮肤以及经过 15 天(加 7 天随访)甘油制剂治疗的特应性皮炎皮肤的 ICLL 进行形态计量分析来测量 SB 完整性。
ICLL 的恢复显示出显著的治疗效果。
该研究表明,ICLL 组织的形态计量分析适用于区分健康和患病皮肤,并对半定量确定非药物甘油制剂的效果。
治疗队列较小。